Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 80
Filter
Add more filters










Publication year range
1.
Mol Psychiatry ; 15(9): 877, 896-904, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20548297

ABSTRACT

Although the higher incidence of stress-related psychiatric disorders in females is well documented, its basis is unknown. Here, we show that the receptor for corticotropin-releasing factor (CRF), the neuropeptide that orchestrates the stress response, signals and is trafficked differently in female rats in a manner that could result in a greater response and decreased adaptation to stressors. Most cellular responses to CRF in the brain are mediated by CRF receptor (CRFr) association with the GTP-binding protein, G(s). Receptor immunoprecipitation studies revealed enhanced CRFr-G(s) coupling in cortical tissue of unstressed female rats. Previous stressor exposure abolished this sex difference by increasing CRFr-G(s) coupling selectively in males. These molecular results mirrored the effects of sex and stress on sensitivity of locus ceruleus (LC)-norepinephrine neurons to CRF. Differences in CRFr trafficking were also identified that could compromise stress adaptation in females. Specifically, stress-induced CRFr association with beta-arrestin2, an integral step in receptor internalization, occurred only in male rats. Immunoelectron microscopy confirmed that stress elicited CRFr internalization in LC neurons of male rats exclusively, consistent with reported electrophysiological evidence for stress-induced desensitization to CRF in males. Together, these studies identified two aspects of CRFr function, increased cellular signaling and compromised internalization, which render CRF-receptive neurons of females more sensitive to low levels of CRF and less adaptable to high levels of CRF. CRFr dysfunction in females may underlie their increased vulnerability to develop stress-related pathology, particularly that related to increased activity of the LC-norepinephrine system, such as depression or post-traumatic stress disorder.


Subject(s)
Corticotropin-Releasing Hormone/metabolism , Protein Transport/physiology , Receptors, Corticotropin-Releasing Hormone/metabolism , Sex Characteristics , Signal Transduction/physiology , Stress, Psychological/metabolism , Animals , Arrestins/metabolism , Cyclic AMP/metabolism , Female , GTP-Binding Protein alpha Subunits, Gs/metabolism , Male , Microscopy, Immunoelectron , Neurons/metabolism , Neurons/ultrastructure , Rats , Rats, Sprague-Dawley , beta-Arrestins
2.
Free Radic Res ; 34(6): 541-81, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11697033

ABSTRACT

The nitration of free tyrosine or protein tyrosine residues generates 3-nitrotyrosine the detection of which has been utilised as a footprint for the in vivo formation of peroxynitrite and other reactive nitrogen species. The detection of 3-nitrotyrosine by analytical and immunological techniques has established that tyrosine nitration occurs under physiological conditions and levels increase in most disease states. This review provides an updated, comprehensive and detailed summary of the tissue, cellular and specific protein localisation of 3-nitrotyrosine and its quantification. The potential consequences of nitration to protein function and the pathogenesis of disease are also examined together with the possible effects of protein nitration on signal transduction pathways and on the metabolism of proteins.


Subject(s)
Nitrates/metabolism , Proteins/physiology , Signal Transduction , Tyrosine/analogs & derivatives , Tyrosine/metabolism , Animals , Disease , Humans , Proteins/metabolism , Tyrosine/analysis , Tyrosine/physiology
3.
J Biol Chem ; 276(49): 46017-23, 2001 Dec 07.
Article in English | MEDLINE | ID: mdl-11590168

ABSTRACT

Tyrosine hydroxylase (TH) is modified by nitration after exposure of mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydrophenylpyridine. The temporal association of tyrosine nitration with inactivation of TH activity in vitro suggests that this covalent post-translational modification is responsible for the in vivo loss of TH function (Ara, J., Przedborski, S., Naini, A. B., Jackson-Lewis, V., Trifiletti, R. R., Horwitz, J., and Ischiropoulos, H. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 7659-7663). Recent data showed that cysteine oxidation rather than tyrosine nitration is responsible for TH inactivation after peroxynitrite exposure in vitro (Kuhn, D. M., Aretha, C. W., and Geddes, T. J. (1999) J. Neurosci. 19, 10289-10294). However, re-examination of the reaction of peroxynitrite with purified TH failed to produce cysteine oxidation but resulted in a concentration-dependent increase in tyrosine nitration and inactivation. Cysteine oxidation is only observed after partial unfolding of the protein. Tyrosine residue 423 and to lesser extent tyrosine residues 428 and 432 are modified by nitration. Mutation of Tyr(423) to Phe resulted in decreased nitration as compared with wild type protein without loss of activity. Stopped-flow experiments reveal a second order rate constant of (3.8 +/- 0.9) x 10(3) m(-1) s(-1) at pH 7.4 and 25 degrees C for the reaction of peroxynitrite with TH. Collectively, the data indicate that peroxynitrite reacts with the metal center of the protein and results primarily in the nitration of tyrosine residue 423, which is responsible for the inactivation of TH.


Subject(s)
Enzyme Inhibitors/pharmacology , Nitrates/metabolism , Peroxynitrous Acid/pharmacology , Tyrosine 3-Monooxygenase/antagonists & inhibitors , Tyrosine 3-Monooxygenase/metabolism , Base Sequence , Circular Dichroism , DNA Primers , Kinetics , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/metabolism
4.
J Neurosci ; 21(20): 8053-61, 2001 Oct 15.
Article in English | MEDLINE | ID: mdl-11588178

ABSTRACT

Brain lesions containing filamentous and aggregated alpha-synuclein are hallmarks of neurodegenerative synucleinopathies. Oxidative stress has been implicated in the formation of these lesions. Using HEK 293 cells stably transfected with wild-type and mutant alpha-synuclein, we demonstrated that intracellular generation of nitrating agents results in the formation of alpha-synuclein aggregates. Cells were exposed simultaneously to nitric oxide- and superoxide-generating compounds, and the intracellular formation of peroxynitrite was demonstrated by monitoring the oxidation of dihydrorhodamine 123 and the nitration of alpha-synuclein. Light microscopy using antibodies against alpha-synuclein and electron microscopy revealed the presence of perinuclear aggregates under conditions in which peroxynitrite was generated but not when cells were exposed to nitric oxide- or superoxide-generating compounds separately. alpha-Synuclein aggregates were observed in 20-30% of cells expressing wild-type or A53T mutant alpha-synuclein and in 5% of cells expressing A30P mutant alpha-synuclein. No evidence of synuclein aggregation was observed in untransfected cells or cells expressing beta-synuclein. In contrast, selective inhibition of the proteasome resulted in the formation of aggregates detected with antibodies to ubiquitin in the majority of the untransfected cells and cells expressing alpha-synuclein. However, alpha-synuclein did not colocalize with these aggregates, indicating that inhibition of the proteasome does not promote alpha-synuclein aggregation. In addition, proteasome inhibition did not alter the steady-state levels of alpha-synuclein, but addition of the lysosomotropic agent ammonium chloride significantly increased the amount of alpha-synuclein, indicating that lysosomes are involved in degradation of alpha-synuclein. Our data indicate that nitrative and oxidative insult may initiate pathogenesis of alpha-synuclein aggregates.


Subject(s)
Intracellular Fluid/metabolism , Kidney/metabolism , Nerve Tissue Proteins/metabolism , Ammonium Chloride/metabolism , Ammonium Chloride/pharmacokinetics , Cell Line , Cysteine Endopeptidases , Enzyme Inhibitors/pharmacology , Humans , Inclusion Bodies/metabolism , Kidney/cytology , Kidney/drug effects , Lysosomes/metabolism , Macromolecular Substances , Multienzyme Complexes/antagonists & inhibitors , Nerve Tissue Proteins/genetics , Neurodegenerative Diseases/metabolism , Nitrates/metabolism , Nitric Oxide/biosynthesis , Nitric Oxide/pharmacology , Oxidants/pharmacology , Proteasome Endopeptidase Complex , Protein Binding/drug effects , Protein Binding/physiology , Superoxides/metabolism , Superoxides/pharmacology , Synucleins , Transfection , Ubiquitins/metabolism , alpha-Synuclein , beta-Synuclein
5.
Proc Natl Acad Sci U S A ; 98(20): 11575-80, 2001 Sep 25.
Article in English | MEDLINE | ID: mdl-11562476

ABSTRACT

One of the many biological functions of nitric oxide is the ability to protect cells from oxidative stress. To investigate the potential contribution of low steady state levels of nitric oxide generated by endothelial nitric oxide synthase (eNOS) and the mechanisms of protection against H(2)O(2), spontaneously transformed human ECV304 cells, which normally do not express eNOS, were stably transfected with a green fluorescent-tagged eNOS cDNA. The eNOS-transfected cells were found to be resistant to injury and delayed death following a 2-h exposure to H(2)O(2) (50-150 microM). Inhibition of nitric oxide synthesis abolished the protective effect against H(2)O(2) exposure. The ability of nitric oxide to protect cells depended on the presence of respiring mitochondria as ECV304+eNOS cells with diminished mitochondria respiration (rho(-)) are injured to the same extent as nontransfected ECV304 cells and recovery of mitochondrial respiration restores the ability of nitric oxide to protect against H(2)O(2)-induced death. Nitric oxide also found to have a profound effect in cell metabolism, because ECV304+eNOS cells had lower steady state levels of ATP and higher utilization of glucose via the glycolytic pathway than ECV304 cells. However, the protective effect of nitric oxide against H(2)O(2) exposure is not reproduced in ECV304 cells after treatment with azide and oligomycin suggesting that the dynamic regulation of respiration by nitric oxide represent a critical and unrecognized primary line of defense against oxidative stress.


Subject(s)
Cell Survival/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , Oxidative Stress , Oxygen Consumption/drug effects , Adenosine Triphosphate/metabolism , Azides/pharmacology , Cell Line , Cells, Cultured , Glucosephosphate Dehydrogenase/metabolism , Humans , Hydrogen Peroxide/pharmacology , Kinetics , Luminescent Measurements , NADP/metabolism , Oligomycins/pharmacology
6.
Am J Physiol Cell Physiol ; 281(3): C833-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11502560

ABSTRACT

An elevation in inorganic phosphate (P(i)) concentration activates epiphyseal chondrocyte apoptosis. To determine the mechanism of apoptosis, tibial chondrocytes were treated with P(i), and nitrate/nitrite (NO/NO) levels were determined. P(i) induced a threefold increase in the NO/NO concentration; inhibitors of nitric oxide (NO) synthase activity and P(i) transport significantly reduced NO/NO levels and prevented cell death. Furthermore, a dose-dependent increase in cell death was observed after exposure of chondrocytes to S-nitrosoglutathione. P(i) increased caspase 3 activity 2.7-fold. Both caspase 1 and caspase 3 inhibitors protected chondrocytes from P(i)-induced apoptosis. P(i) caused a significant decrease in the mitochondrial membrane potential, while NO synthase inhibitors maintained mitochondrial function. While P(i) caused thiol depletion, inhibition of P(i) uptake or NO generation served to maintain glutathione levels. The results suggest that NO serves to mediate key metabolic events linked to P(i)-dependent chondrocyte apoptosis.


Subject(s)
Apoptosis/physiology , Chondrocytes/cytology , Chondrocytes/physiology , Nitric Oxide/physiology , omega-N-Methylarginine/pharmacology , Animals , Apoptosis/drug effects , Caspase 1/metabolism , Caspase 3 , Caspase Inhibitors , Caspases/metabolism , Cells, Cultured , Chick Embryo , Chondrocytes/drug effects , Cysteine Proteinase Inhibitors/pharmacology , Enzyme Inhibitors/pharmacology , Glutathione/analogs & derivatives , Glutathione/pharmacology , Growth Plate/cytology , Intracellular Membranes/drug effects , Intracellular Membranes/physiology , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mitochondria/drug effects , Mitochondria/physiology , NG-Nitroarginine Methyl Ester/pharmacology , Nitrates/metabolism , Nitric Oxide Synthase/antagonists & inhibitors , Nitrites/metabolism , Nitroso Compounds/pharmacology , Platelet Aggregation Inhibitors/pharmacology , S-Nitrosoglutathione , Staurosporine/pharmacology
7.
J Cell Physiol ; 187(3): 277-82, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11319751

ABSTRACT

Nitric oxide (NO) has been shown to mediate a number of different physiological functions within every major organ system. This wide variety of functional roles is made all the more remarkable when one considers that NO is a simple diatomic molecule. However, despite the simplicity of the molecule, NO possesses a wide range of chemical reactivity and multiple potential reactive targets. It is the variability of NO reactivity, which leads to its capability to control such a vast range of biological functions. In essence the functionality of NO is controlled by its chemical reactivity. In order to understand this possibility further it is necessary to consider the biologically relevant reactions of nitric oxide.


Subject(s)
Nitric Oxide/chemistry , Nitric Oxide/metabolism , Signal Transduction/physiology , Animals , Electron Transport Complex IV/metabolism , Hemeproteins/metabolism , Humans , Models, Biological , Oxidation-Reduction , Oxides/metabolism , Reactive Oxygen Species/metabolism , Sulfhydryl Compounds/metabolism
8.
Free Radic Biol Med ; 30(6): 679-85, 2001 Mar 15.
Article in English | MEDLINE | ID: mdl-11295366

ABSTRACT

Human lymphocytes were exposed to increasing concentrations of SIN-1, which generates superoxide and nitric oxide, and the formation of single-strand breaks (SSB) in individual cells was determined by the single-cell gel electrophoresis assay (comet assay). A dose- and time-dependent increase in SSB formation was observed rapidly after the addition of SIN-1 (0.1-15 mM). Exposure of the cells to SIN-1 (5 mM) in the presence of excess of superoxide dismutase (0.375 mM) increased the formation of SSB significantly, whereas 1000 U/ml catalase significantly decreased the quantity of SSB. The simultaneous presence of both superoxide dismutase and catalase before the addition of SIN-1 brought the level of SSB to that of the untreated cells. Moreover, pretreatment of the cells with the intracellular Ca(2+)-chelator BAPTA/AM inhibited SIN-1-induced DNA damage, indicating the involvement of intracellular Ca(2+) changes in this process. On the other hand, pretreatment of the same cells with ascorbate or dehydroascorbate did not offer any significant protection in this system. The data suggest that H2O2-induced changes in Ca(2+) homeostasis are the predominant pathway for the induction of SSB in human lymphocytes exposed to oxidants.


Subject(s)
Comet Assay , DNA Damage/drug effects , Lymphocytes/drug effects , Molsidomine/pharmacology , Nitric Oxide Donors/pharmacology , Ascorbic Acid/analogs & derivatives , Ascorbic Acid/pharmacology , Calcium/metabolism , Catalase/metabolism , Chelating Agents/pharmacology , DNA, Single-Stranded/drug effects , DNA, Single-Stranded/genetics , DNA, Single-Stranded/metabolism , Data Interpretation, Statistical , Dose-Response Relationship, Drug , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Flow Cytometry , Humans , Kinetics , Lymphocytes/metabolism , Microscopy, Ultraviolet , Molsidomine/analogs & derivatives , Molsidomine/antagonists & inhibitors , Nitrates/metabolism , Nitric Oxide Donors/antagonists & inhibitors , Superoxide Dismutase/metabolism
10.
Cancer Res ; 61(2): 778-84, 2001 Jan 15.
Article in English | MEDLINE | ID: mdl-11212282

ABSTRACT

Cigarette smoking is a cause of lung cancer and other respiratory diseases. Oxidants either present in cigarette smoke and/or formed in the lung of smokers may trigger oxidative and nitrative damage to DNA and cellular components, contributing to carcinogenesis. We have used immunodot and Western blot analyses to measure nitrated (nitrotyrosine-containing) and oxidized (carbonyl-containing) proteins in plasma samples collected from 52 lung cancer patients and 43 control subjects (heavy and light smokers, nonsmokers with or without exposure to environmental tobacco smoke). The levels of nitrated proteins were significantly higher in lung cancer patients than in controls (P = 0.003). On the other hand, the levels of oxidized proteins were significantly higher in smokers than in nonsmokers (P < 0.001). Western-blot analyses showed the presence of two to five nitrated proteins and one oxidized protein. Using immunoprecipitation and Western-blot analyses with eight different antibodies against human plasma proteins, we identified fibrinogen, transferrin, plasminogen, and ceruloplasmin as nitrated proteins and fibrinogen as the only oxidized protein present in human plasma of lung cancer patients and smokers. Our results indicate that cigarette smoking increases oxidative stress and that during lung cancer development, formation of reactive nitrogen species results in nitration and oxidation of plasma proteins.


Subject(s)
Blood Proteins/metabolism , Lung Neoplasms/blood , Nitrates/metabolism , Smoking/adverse effects , Tyrosine/analogs & derivatives , Aged , Aged, 80 and over , Blotting, Western , Female , Humans , Immunoblotting , Lung Neoplasms/etiology , Male , Middle Aged , Multivariate Analysis , Oxidation-Reduction , Precipitin Tests , Tyrosine/metabolism
11.
J Neurochem ; 76(2): 637-40, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11208927

ABSTRACT

Structural and functional alterations of alpha-synuclein is a presumed culprit in the demise of dopaminergic neurons in Parkinson's disease (PD). Alpha-synuclein mutations are found in familial but not in sporadic PD, raising the hypothesis that effects similar to those of familial PD-linked alpha-synuclein mutations may be achieved by oxidative post-translational modifications. Here, we show that wild-type alpha-synuclein is a selective target for nitration following peroxynitrite exposure of stably transfected HEK293 cells. Nitration of alpha-synuclein also occurs in the mouse striatum and ventral midbrain following administration of the parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Conversely, beta-synuclein and synaptophysin were not nitrated in MPTP-intoxicated mice. Our data demonstrate that alpha-synuclein is a target for tyrosine nitration, which, by disrupting its biophysical properties, may be relevant to the putative role of alpha-synuclein in the neurodegeneration associated with MPTP toxicity and with PD.


Subject(s)
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine , Nerve Tissue Proteins/metabolism , Parkinsonian Disorders/metabolism , Protein Processing, Post-Translational/physiology , Animals , Cell Line , Corpus Striatum/chemistry , Corpus Striatum/drug effects , Corpus Striatum/metabolism , Disease Models, Animal , Humans , Kidney/chemistry , Kidney/cytology , Kidney/drug effects , Kidney/metabolism , Male , Mice , Mice, Inbred C57BL , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/genetics , Oxidation-Reduction/drug effects , Parkinsonian Disorders/chemically induced , Peroxynitrous Acid/pharmacology , Precipitin Tests , Synaptophysin/analysis , Synaptophysin/metabolism , Synucleins , Transfection , Tyrosine/chemistry , Tyrosine/drug effects , Tyrosine/metabolism , alpha-Synuclein , beta-Synuclein
13.
Am J Pathol ; 157(5): 1439-45, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11073803

ABSTRACT

Reactive nitrogen species may play a mechanistic role in neurodegenerative diseases by posttranslationally altering normal brain proteins. In support of this hypothesis, we demonstrate that an anti-3-nitrotyrosine polyclonal antibody stains all of the major hallmark lesions of synucleinopathies including Lewy bodies, Lewy neurites and neuraxonal spheroids in dementia with Lewy bodies, the Lewy body variant of Alzheimer's disease, and neurodegeneration with brain iron accumulation type 1, as well as glial and neuronal cytoplasmic inclusions in multiple system atrophy. This antibody predominantly recognized nitrated alpha-synuclein when compared to other in vitro nitrated constituents of these pathological lesions, such as neurofilament subunits and microtubules. Collectively, these findings imply that alpha-synuclein is nitrated in pathological lesions. The widespread presence of nitrated alpha-synuclein in diverse intracellular inclusions suggests that oxidation/nitration is involved in the onset and/or progression of neurodegenerative diseases.


Subject(s)
Brain Diseases/metabolism , Inclusion Bodies/metabolism , Nerve Tissue Proteins/metabolism , Neurodegenerative Diseases/metabolism , Nitrates/metabolism , Tyrosine/analogs & derivatives , Adult , Aged , Aged, 80 and over , Antibodies/immunology , Blotting, Western , Brain Diseases/pathology , Female , Humans , Immunohistochemistry , Lewy Bodies/metabolism , Male , Middle Aged , Neurodegenerative Diseases/pathology , Neuroglia/metabolism , Synucleins , Tissue Distribution , Tyrosine/immunology , Tyrosine/metabolism , alpha-Synuclein
14.
Science ; 290(5493): 985-9, 2000 Nov 03.
Article in English | MEDLINE | ID: mdl-11062131

ABSTRACT

Aggregated alpha-synuclein proteins form brain lesions that are hallmarks of neurodegenerative synucleinopathies, and oxidative stress has been implicated in the pathogenesis of some of these disorders. Using antibodies to specific nitrated tyrosine residues in alpha-synuclein, we demonstrate extensive and widespread accumulations of nitrated alpha-synuclein in the signature inclusions of Parkinson's disease, dementia with Lewy bodies, the Lewy body variant of Alzheimer's disease, and multiple system atrophy brains. We also show that nitrated alpha-synuclein is present in the major filamentous building blocks of these inclusions, as well as in the insoluble fractions of affected brain regions of synucleinopathies. The selective and specific nitration of alpha-synuclein in these disorders provides evidence to directly link oxidative and nitrative damage to the onset and progression of neurodegenerative synucleinopathies.


Subject(s)
Brain/metabolism , Nerve Tissue Proteins/metabolism , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/pathology , Oxidative Stress , Tyrosine/analogs & derivatives , Tyrosine/metabolism , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Antibodies, Monoclonal , Blotting, Western , Brain/pathology , Brain Chemistry , Enzyme-Linked Immunosorbent Assay , Fluorescent Antibody Technique , Humans , Immunohistochemistry , Lewy Bodies/chemistry , Lewy Body Disease/metabolism , Lewy Body Disease/pathology , Microscopy, Immunoelectron , Multiple System Atrophy/metabolism , Multiple System Atrophy/pathology , Nerve Tissue Proteins/analysis , Nerve Tissue Proteins/immunology , Neurons/chemistry , Neurons/metabolism , Neurons/ultrastructure , Parkinson Disease/metabolism , Parkinson Disease/pathology , Synucleins , Tyrosine/analysis , Tyrosine/immunology , alpha-Synuclein
15.
Arch Biochem Biophys ; 380(2): 360-6, 2000 Aug 15.
Article in English | MEDLINE | ID: mdl-10933892

ABSTRACT

Tyrosine nitration is a covalent posttranslational protein modification that has been detected under several pathological conditions. This study reports that nitrated proteins are degraded by chymotrypsin and that protein nitration enhances susceptibility to degradation by the proteasome. Chymotrypsin cleaved the peptide bond between nitrated-tyrosine 108 and serine 109 in bovine Cu,Zn superoxide dismutase. However, the rate of chymotryptic cleavage of nitrated peptides was considerably slower than control. In contrast, nitrated bovine Cu,Zn superoxide dismutase was degraded at a rate 1. 8-fold faster than that of control by a gradient-purified 20S/26S proteasome fraction from bovine retina. Exposure of PC12 cells to a nitrating agent resulted in the nitration of tyrosine hydroxylase and a 58 +/- 12.5% decline in the steady-state levels of the protein 4 h after nitration. The steady-state levels of tyrosine hydroxylase were restored by selective inhibition of the proteasome activity with lactacystin. These data indicate that nitration of tyrosine residue(s) in proteins is sufficient to induce an accelerated degradation of the modified proteins by the proteasome and that the proteasome may be critical for the removal of nitrated proteins in vivo.


Subject(s)
Endopeptidases/metabolism , Nitrates/chemistry , Proteins/chemistry , Proteins/metabolism , Tyrosine/chemistry , Animals , Cattle , Chymotrypsin/metabolism , Cysteine Endopeptidases/metabolism , In Vitro Techniques , Kinetics , Multienzyme Complexes/metabolism , PC12 Cells , Proteasome Endopeptidase Complex , Protein Processing, Post-Translational , Rats , Superoxide Dismutase/chemistry , Superoxide Dismutase/metabolism , Tyrosine 3-Monooxygenase/chemistry , Tyrosine 3-Monooxygenase/metabolism
16.
J Exp Med ; 192(2): 227-36, 2000 Jul 17.
Article in English | MEDLINE | ID: mdl-10899909

ABSTRACT

The contribution of the NADPH phagocyte oxidase (phox) and inducible nitric oxide (NO) synthase (iNOS) to the antimicrobial activity of macrophages for Salmonella typhimurium was studied by using peritoneal phagocytes from C57BL/6, congenic gp91phox(-/)-, iNOS(-/)-, and doubly immunodeficient phox(-/)-iNOS(-/)- mice. The respiratory burst and NO radical (NO.) made distinct contributions to the anti-Salmonella activity of macrophages. NADPH oxidase-dependent killing is confined to the first few hours after phagocytosis, whereas iNOS contributes to both early and late phases of antibacterial activity. NO-derived species initially synergize with oxyradicals to kill S. typhimurium, and subsequently exert prolonged oxidase-independent bacteriostatic effects. Biochemical analyses show that early killing of Salmonella by macrophages coincides with an oxidative chemistry characterized by superoxide anion (O(2).(-)), hydrogen peroxide (H(2)O(2)), and peroxynitrite (ONOO(-)) production. However, immunofluorescence microscopy and killing assays using the scavenger uric acid suggest that peroxynitrite is not responsible for macrophage killing of wild-type S. typhimurium. Rapid oxidative bacterial killing is followed by a sustained period of nitrosative chemistry that limits bacterial growth. Interferon gamma appears to augment antibacterial activity predominantly by enhancing NO. production, although a small iNOS-independent effect was also observed. These findings demonstrate that macrophages kill Salmonella in a dynamic process that changes over time and requires the generation of both reactive oxidative and nitrosative species.


Subject(s)
Macrophages, Peritoneal/immunology , Membrane Glycoproteins/physiology , NADPH Oxidases/physiology , Nitric Oxide Synthase/physiology , Phagocytosis , Salmonella typhimurium/immunology , Animals , Macrophage Activation , Macrophages, Peritoneal/metabolism , Mice , Mice, Inbred C57BL , NADPH Oxidase 2 , Nitric Oxide Synthase Type II , Reactive Oxygen Species , Superoxides/metabolism , Tyrosine/analogs & derivatives , Tyrosine/metabolism
17.
Pediatr Res ; 47(6): 798-805, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10832741

ABSTRACT

Inhaled nitric oxide (INO) therapy is currently used clinically to selectively dilate the pulmonary vasculature and to help treat persistent pulmonary hypertension and bronchopulmonary dysplasia in the neonate. However, in the presence of oxygen or superoxide, nitric oxide forms potentially harmful reactive nitrogen species. Using an experimental mice model, we examined the effects of concurrent hyperoxia and INO on protein tyrosine nitration and cysteine S-nitrosylation in pulmonary tissue. Data showed enhanced 3-nitrotyrosine staining within the airway epithelium and alveolar interstitium of mice lungs treated with hyperoxia, which did not increase significantly with INO administration. Within the alveolar interstitium, 3-nitrotyrosine staining was localized to macrophages. S-Nitrosocysteine staining in airway epithelium was significantly enhanced with INO administration regardless of oxygen content. These data suggest that the formation of protein S-nitrosocysteine is the major protein modification during administration of INO.


Subject(s)
Cysteine/analogs & derivatives , Nitric Oxide/therapeutic use , Nitroso Compounds/metabolism , S-Nitrosothiols , Tyrosine/analogs & derivatives , Administration, Inhalation , Animals , Cysteine/metabolism , Epithelium/metabolism , Female , Immunohistochemistry , Lung/metabolism , Mice , Nitric Oxide/administration & dosage , Tyrosine/metabolism
18.
FEBS Lett ; 474(1): 116-9, 2000 May 26.
Article in English | MEDLINE | ID: mdl-10828462

ABSTRACT

Synucleins are a family of small proteins that are predominantly expressed in neurons. The functions of the synucleins are not entirely understood, but they have been implicated in the pathogenesis of several neurodegenerative diseases. Our data show that alpha-, beta- or gamma-synuclein suppresses the aggregation of thermally denatured alcohol dehydrogenase and chemically denatured insulin. The A53T but not the A30P mutant alpha-synuclein was able to inhibit the aggregation of insulin and the chaperone-like activity of alpha-synuclein was lost upon removal of its C-terminal residues 98-140. These results demonstrate that synucleins with the exception of the A30P mutant possess chaperone-like activity.


Subject(s)
Molecular Chaperones/pharmacology , Nerve Tissue Proteins/pharmacology , Alcohol Dehydrogenase/chemistry , Disulfides/chemistry , Dithiothreitol/pharmacology , Escherichia coli , Hot Temperature , Humans , Insulin/chemistry , Mutation , Nerve Tissue Proteins/genetics , Protein Denaturation , Recombinant Proteins/pharmacology , Ribonuclease, Pancreatic/chemistry , Synucleins , alpha-Synuclein , gamma-Synuclein
19.
Am J Physiol Cell Physiol ; 278(6): C1099-107, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10837337

ABSTRACT

To better understand the mechanism(s) underlying nitric oxide (. NO)-mediated toxicity, in the presence and absence of concomitant oxidant exposure, postmitotic terminally differentiated NT2N cells, which are incapable of producing. NO, were exposed to PAPA-NONOate (PAPA/NO) and 3-morpholinosydnonimine (SIN-1). Exposure to SIN-1, which generated peroxynitrite in the range of 25-750 nM/min, produced a concentration- and time-dependent delayed cell death. In contrast, a critical threshold concentration (>440 nM/min) was required for. NO to produce significant cell injury. Examination of cells by electron microscopy shows a largely necrotic injury after peroxynitrite exposure but mainly apoptotic-like morphology after. NO exposure. Cellular levels of reduced thiols correlated with cell death, and pretreatment with N-acetylcysteine (NAC) fully protected from cell death in either PAPA/NO or SIN-1 exposure. NAC given within the first 3 h posttreatment further delayed cell death and increased the intracellular thiol level in SIN-1 but not. NO-exposed cells. Cell injury from. NO was independent of cGMP, caspases, and superoxide or peroxynitrite formation. Overall, exposure of non-. NO-producing cells to. NO or peroxynitrite results in delayed cell death, which, although occurring by different mechanisms, appears to be mediated by the loss of intracellular redox balance.


Subject(s)
Neurons/cytology , Neurons/physiology , Nitric Oxide Donors/pharmacology , Nitric Oxide/physiology , Sulfhydryl Compounds/pharmacology , Acetylcysteine/pharmacology , Animals , Cell Death/drug effects , Cell Death/physiology , Cell Differentiation , Cell Line , Cell Survival/drug effects , Cyclic GMP/analogs & derivatives , Cyclic GMP/metabolism , Cyclic GMP/pharmacology , Hydrazines/pharmacology , Molsidomine/analogs & derivatives , Molsidomine/pharmacology , Necrosis , Neurons/drug effects , Nitrates/pharmacology , Nitric Oxide/pharmacology , Oxidants/pharmacology
20.
Free Radic Biol Med ; 28(7): 1132-6, 2000 Apr 01.
Article in English | MEDLINE | ID: mdl-10832075

ABSTRACT

The oxygen-insensitive nitroreductases nfsA and nfsB are known to reduce para-nitrated aromatic compounds. We tested the hypothesis that these nitroreductases are capable of reducing 3-nitrotyrosine in proteins and peptides, as well as in free amino acids using wild-type and nfsA nfsB mutant strains of Escherichia coli. E. coli homogenates were incubated with nitrated proteins and the level of 3-nitrotyrosine immunoreactivity was assayed by Western blotting. Assay conditions that allow the nitroreductases to rapidly reduce nitrofurantoin did not result in the modification of 3-nitrotyrosine in protein, peptide, or free amino acid. Stimulation of nfsA nfsB activity with paraquat had no effect on 3-nitrotyrosine reduction. Nonlethal exposure of E. coli to peroxynitrite/CO(2) resulted in the reproducible nitration of tyrosine residues in endogenous proteins. The degree of 3-nitrotyrosine immunoreactivity over the 2-h postexposure period did not differ between mutant and wild-type strains. These results indicate that the nfsA and nfsB enzymes do not reduce 3-nitrotyrosine.


Subject(s)
Bacterial Proteins/physiology , Drug Resistance, Neoplasm , Escherichia coli Proteins , Escherichia coli/enzymology , Nitroreductases/physiology , Oxygen/toxicity , Tyrosine/analogs & derivatives , Tyrosine/metabolism , Cell Fractionation , Enzyme Induction/drug effects , Escherichia coli/drug effects , Escherichia coli/metabolism , Nitrates/metabolism , Nitroreductases/biosynthesis , Oxidation-Reduction , Paraquat/pharmacology , Peptides/metabolism , Reducing Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...